Company: PIII
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015305
Chunk: 163

Company: P3 Health Partners Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7
Chunk 163
---
,442 (367,344)142,130 Exchanges of redeemable non-controlling interest for Class A common stock—612— (612)— — —— Issuance of Class A common stock upon settlement of restricted stock units, net of shares withheld for tax—4,066———(103)—(103)Equity-based compensation—————5,752 —5,752 Fair value adjustment to redeemable non-controlling interest(20,579)————20,579 —20,579 Remeasurement adjustment to redeemable non-controlling interest resulting from ownership changes(22,831)— — — — 22,831 — 22,831 Private placement, net of offering costs—41,6044——8,465 —8,469 Class A common stock warrants issued—————12,127 —12,127 Net loss(174,529)— — — — — (135,849)(135,849)STOCKHOLDERS’ EQUITY, December 31, 2024$73,593 162,870 $16 195,957 $20 $579,093 $(503,193)$75,936 

See accompanying notes to consolidated financial statements.

P3 Health Partners Inc. | 2024 Form 10-K | 81

P3 HEALTH PARTNERS INC. and SUBSIDIARIES 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

Year Ended December 31,20242023CASH FLOWS FROM OPERATING ACTIVITIES:Net loss$(310,378)$(186,426)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization86,058 86,675 Equity-based compensation5,752 5,979 Amortization of original issue discount and debt issuance costs87 472 Accretion of contingent consideration— 113 Gain on write off of contingent consideration(4,907)— Gain on asset sale(13,269)— Deferred income taxes(1,090)— Impairment of assets held for sale8,058 — Mark-to-market adjustment of stock warrants(22,114)(433)Premium deficiency reserve53,698 (12,705)Changes in operating assets and liabilities:Health plan receivable(2,769)(46,555)Clinic fees